On Tuesday, Olema Pharmaceuticals Inc (NASDAQ: OLMA) was -5.61% drop from the session before, before settling in for the closing price of $11.06. A 52-week range for OLMA has been $2.86 – $13.51.
Healthcare Sector giant saw their annual sales slid by -83.00% over the last five years. When this article was written, the company’s average yearly earnings per share was at 14.29%. With a float of $52.86 million, this company’s outstanding shares have now reached $68.63 million.
Olema Pharmaceuticals Inc (OLMA) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Olema Pharmaceuticals Inc stocks. The insider ownership of Olema Pharmaceuticals Inc is 22.99%, while institutional ownership is 85.70%. The most recent insider transaction that took place on Sep 18 ’25, was worth 83,300. In this transaction Director of this company sold 10,000 shares at a rate of $8.33, taking the stock ownership to the 744,140 shares. Before that another transaction happened on Sep 16 ’25, when Company’s Director sold 10,000 for $8.04, making the entire transaction worth $80,400. This insider now owns 754,140 shares in total.
Olema Pharmaceuticals Inc (OLMA) Earnings and Forecasts
Going through the last 3-months fiscal report unveiled on the 9/30/2024, it has been observed that the corporation posted -0.6 earnings per share (EPS) during the time that was less than consensus figure (set at -0.57) by -0.03. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.47 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 14.29% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 0.90% during the next five years compared to -83.00% drop over the previous five years of trading.
Olema Pharmaceuticals Inc (NASDAQ: OLMA) Trading Performance Indicators
You can see what Olema Pharmaceuticals Inc (OLMA) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 15.22.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.92, a number that is poised to hit -0.47 in the next quarter and is forecasted to reach -2.17 in one year’s time.
Technical Analysis of Olema Pharmaceuticals Inc (OLMA)
Analysing the last 5-days average volume posted by the [Olema Pharmaceuticals Inc, OLMA], we can find that recorded value of 1.32 million was better than the volume posted last year of 0.93 million. As of the previous 9 days, the stock’s Stochastic %D was 80.84%.
During the past 100 days, Olema Pharmaceuticals Inc’s (OLMA) raw stochastic average was set at 85.58%, which indicates a significant increase from 71.58% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.80 in the past 14 days, which was higher than the 0.44 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $7.02, while its 200-day Moving Average is $5.36. Now, the first resistance to watch is $10.98. This is followed by the second major resistance level at $11.51. The third major resistance level sits at $11.88. If the price goes on to break the first support level at $10.07, it is likely to go to the next support level at $9.70. Should the price break the second support level, the third support level stands at $9.16.
Olema Pharmaceuticals Inc (NASDAQ: OLMA) Key Stats
There are 68,634K outstanding shares of the company, which has a market capitalization of 716.55 million. As of now, sales total 0 K while income totals -129,470 K. Its latest quarter income was 0 K while its last quarter net income were -43,780 K.
